General Cardiovascular Flashcards by Cameron st

Adenosine (Adenocard)

Type: Antidysrhythmic
____________

MOA:
Short-acting drug that slows conduction through the AV node; Restore sinus rhythm in patients with SVT and Terminates regular tachycardias caused by reentrant AV nodal pathways
____________

Indications: First-line drug for most forms of stable, regular, narrow-complex SVT | Can be considered for marrow-complex reentry tachycardia while preparing for cardioversion | Can be used diagnostically for stable, regular, monomorphic wide-complex tachycardia
____________

Contraindications: Known hypersensitivity | Second- or third-degree AV block or sick sinus syndrome or other sinus node disease | Poison- or drug-induced tachycardia | Use with caution in patients with a history of seizure disorder | May induce bronchospasm in a patient with bronchoconstrictive or bronchospastic lung disease (ex: asthma and COPD)
____________

Adverse Reactions: Generally transient and of short duration | Flushing, sweating, dizziness, nervousness, paresthesia, hypotension, feeling of impending doom, severe bronchospasm | A brief period of most any dysrhythmia (like asystole) can occur during pharmacologic conversion
____________

Drug Interactions: Additive effects are possible if used in combination with beta blockers | Methylxanthines (like caffine and theophylline-like drugs) block the actions of adenosine | Dipyridamole (Persantine) potentiates the effect | Carbamazepine (Tegretol) may potentiate the AV node blocking effect | Nicotine can enhance the cardiovascular effects | An increase in angina-like chest discomfort or heart rate | A decrease in BP may be observed
____________

Dosages:
Adult.
6-mg rapid IV/IO bolus over 1 to 3 second followed by a 10-mL saline flush; Additional 12-mg dose if needed after 1 to 2 minutes over the same time frame; Maximum total dosage is 30 mg

Paediatric.
Initial dose 0.1 mg/kg (max first dose of 6mg) rapid IV/IO push over 1 to 3 seconds followed by a 5- to 10-mL saline flush; Second dose 0.2 mg/kg (max second dose of 12mg) rapid IV/IO push followed by a 5- to 10-mL saline flush
____________

Duration: Onset: Seconds | Peak effect: Seconds | Duration: 10 seconds
____________

Special Conditions: Pregnancy safety: Category C | Monitor the ECG and record a rhythm, strip during administration | Ineffective in converting AF, atrial flutter, or VT | Should NOT be administered for hemodynamically unstable, irregularly irregular, or polymorphic wide-complex tachycardias

How well did you know this?

Not at all

Perfectly

Amiodarone (Cordarone, Pacerone)

Type: Antidysrhythmic (Class III)
____________

MOA:
Blocks sodium, potassium, and calcium channels; Prolongs the action potential’s duration and Delays repolarization; Decreases AV conduction and sinoatrial (SA) node function
____________

Indications: Cardiac arrest resulting from VF or pulseless VT after CPR, defibrillation, and epinephrine | Stable, regular narrow-complex tachycardia if the rhythm persists despite vagal maneuvers or adenosine or the tachycardia is recurrent | To control the ventricular rate in AF with a rapid ventricular response without preexcitation | Stable wide-complex tachycardia | Stable monomorphic VT | Polymorphic VT with a normal QT interval
____________

Contraindications: Known hypersensitivity | Iodine hypersensitivity | Cardiogenic shock | Second- of third-degree AV block | Sick sinus syndrome or other sinuse node disease (unless a functioning artificial pacemaker is present)
____________

Drug Interactions: May increase the effects of digoxin, disopyramide, fentanyl, lidocaine, procainamide, quinidine, or warfarin | Cimetidine may increase amiodarone levels | Use with beta blockers or calcium channel blockers may potentiate bradycardia, sinus arrest, and AV blocks | Persistent use of echinacea can potentiate amiodarone’s hepatotoxic effects
____________

Dosages:
Adult.
Initial dose 300 mg IV/IO push ; Second dose 150 mg IV/IO push ; Loading dose 150 mg IV/IO over 10 minutes ; Max cumulative dose of 2.2 g IV/IO per 24 hours

Paediatric.
Refractory VF/pulseless VT: 5 mg/kg IV/IO bolus ; can repeat if needed to max cumulative dose of 15mg/kg IV per 24 hours (2.2g in adolescents per 24 hours) ; Max single dose of 300mg.
Poor perfusing ventricular or atrial sysrhythmias: loading dose 5mg/kg IV/IO over 20 to 60 minutes (max single dose of 300mg) ; can repeat if needed to max cumulative dose of 15mg/kg IV per 24 hours (2.2g in adolescents per 24 hours)
____________

Duration: Onset: 2 hours | Peak effect: 3 to 7 hours | Duration: Variabled
____________

Special Conditions: Pregnancy safety: Category D ; may cause fetal death ; Lactating women should not breastfeed following use | May worsen or precipitate new dysrhythmias | Monitor for hypotension and increasing PR and QT intervals | Dosage may change per the most current International Liaison Committee on Resuscitation (ILCOR) recommendations

How well did you know this?

Not at all

Perfectly

Aspirin (Acetylsalicylic Acid)

Type: Platelet inhibitor, NSAID, Anti-inflammatory agent
____________

MOA:
Prevents thromboxane A2 formation to prevent platelet aggregation and plug formations | Has antipyretic and analgesic properties
____________

Indications: New-onset chest discomfort suggestive of ACS
____________

Contraindications: Hypersensitivity to ASA or NSAIDs | Bleeding disorders | Hemolytic anemia | Lactating mothers
____________

Drug Interactions: Increased risk of bleeding with anticoagulants and other NSAIDs | Diminished effects of ACE inhibitors and loop diuretics | Antacids reduce ASA absorption | Increased risk of hypoglycemia occurs with administration of oral hypoglycemic drugs | Effects are decreased by corticosteroids | Increased bleeding can occur when ASA is taken with certain herbs (ex: quai, feverfew, garlic, ginger, ginkgo, Korean ginseng, and saw plametto - because these herbs interfere w/ platelet aggregation)
____________

Dosages:
Adult.
162 mg to 325 mg orally (chewable)

Paediatric.
Not recommended
____________

Duration: Onset: 15 to 30 minutes | Peak effect: 1 to 2 hours | Duration: 4 to 6 hours
____________

Special Conditions: Pregnancy safety: Category D | If there are no contraindications, non–enteric-coated, chewable aspirin should be given as soon as possible to all patients with a suspected ACS after symptom onset

How well did you know this?

Not at all

Perfectly

Digoxin (Lanoxin)

Type: Inotropic agent, Cardiac glycoside, Antidysrhythmic
____________

MOA:
(not listed per textbook)
____________

Indications: Heart failure | alternative frug for reentry SVT | ventricular rate control in atrial flutter and AF
____________

Contraindications: Known hypersensitivity | VF | VT | digitalis toxicity | Hypokalemia, hypomagnesemia, and hypercalcemia potentiate digitalis toxicity
____________

Drug Interactions: Amiodarone, verapamil, and quinidine may increase serum digoxin concentrations | concurrent use of digoxin and verapamill may lead to severe AV block | Diuretics may potentiate cardiac toxicity | St. John’s wort can reduce the effects of digoxin effectiveness and licorice can potentiate its effects
____________

Dosages:
(not listed per textbook)
____________

Duration: (not listed per textbook)
____________

Special Conditions: Can prolong the PR interval and cause ST-segment changes on the EKG; careful cardiac monitoring is essential | Calcuim channel blockers or beta blockers are generally preferred for heart rate control in pts w/ AF; adenosine is preferred to tx reentry SVT | Cardioversion should be AVOIDED if pt is taking digoxin, but if the situation is life-threatening, use a lower energy dose (10 to 20 joules)

How well did you know this?

Not at all

Perfectly

Diltiazem (Cardizem, Dilacor, Diltiaz)

Type: Calcium channel blocker, Antidysrhythmic (Class IV), Antianginal agent
____________

MOA:
Inhibits extracellular calcium ion influx across membranes of myocardial cells and vascular smooth muscle cells, resulting in inhibition of cardiac and vascular smooth muscle coontraction and therby dilating the main coronary and sestemic arteries | No effect on serum calcium concentrations | Substantial inhibitory effects on the cardiac conduction system, acting principally at the AV node, w/ some effects at the SA node | Less-negative inotropic effects than verapamil
____________

Indications: Stable narrow-QRS tachycardia; if Rhythm persists despite vagal maneuvers or administration of adenosine, or if the tachycardia is recurrent | To control the ventricular rate in patients with AF or atrial flutter without preexcitation
____________

Contraindications: Known hypersensitivity | Hypotension | Cardiogenic shock | Wide-complex tachycardia (may lead to hemodynamic deterioration and VF) | Second- or third-degree AV block | Sick sinus syndrome or other sinus node disease | Poison- or drug-induced tachycardia | AF or atrial flutter associated with an accessory bypass tract (ex: Wolff-Parkinson-White syndrome or Lown-Ganong-Levine syndrome) | Avoid use in patients with left ventricular systolic dysfunction or decompensated heart failure | Use with extreme caution in patients taking oral beta blockers
____________

Drug Interactions: Use with caution in patients taking medications that affect cardiac contractility | Simultaneous use with IV beta blockers can result in decreased cardiac contractility, bradycardia (including AV blocks), and hypotension | Increased risk of sudden cardiac death when given concurrently with erythromycin
____________

Dosages:
Adult.
Initial dose: 15 to 20 mg (0.25 mg/kg) IV/IO slowly over 2 minutes ; After 15 minutes: a second bolus of 20 to 25 mg (0.35 mg/kg) IV/IO can be given slowly over 2 minutes
Patients older than age 65: require a maximum initial dose of 10 mg IV/IO and second dose of 20 mg IV/IO ; Maintenance infusion: 5 to 15 mg/h titrated to a physiologically appropriate heart rate

Paediatric. Not recommended
____________

Duration: Onset: 2 to 5 minutes | Peak effect: Usually within 7 minutes | Duration: 1 to 3 hours
____________

Special Conditions: Pregnancy safety: Category C | Dysrhythmias may be observed during pharmacologic conversion | Carefully monitor BP and EKG before, during, and after administration

How well did you know this?

Not at all

Perfectly

DOBUTamine Hydrochloride (Dobutrex)

Type: Adrenergic, Inotropic agent
____________

MOA:
Synthetic catecholamine that primarily simulates beta-1 receptors with minor stimulation of beta-2 and alpha-1 receptors | Increases myocardial contractility and stroke volume, resulting in increased cardiac output w/ modest chronotropic effects | Increases renal blood flow secondary to increased cardiac output
____________

Indications: Heart failure with a SBP of 70 to 100 mm Hg and no signs of shock
____________

Contraindications: Known hypersensitivity | Suspected or known poison/drug-induced shock | SBP less than 100 mm Hg and signs of shock | Idiopathic hypertrophic subaortic stenosis
____________

Drug Interactions: Incompatible with sodium bicarbonate and furosemide | Beta blockers may blunt the inotropic effects
____________

Dosages:
Adult.
IV infusion at 2 to 20 mcg/kg/min titrated to desired effect

Paediatric.
IV infusion at 2 to 20 mcg/kg/min titrated to desired effect
____________

Duration: Onset: 2 minutes | Peak effect: 10 minutes | Duration: 1 to 2 minutes after infusion discontinued
____________

Special Conditions: Pregnancy safety: Category B | BP and hemodynamic monitoring recommended | Titrate dose to maintain a heart rate increase of no greater than 10% of baseline | May increase infarct size in patients with MI | May precipitate or exacerbate ventricular ectopy | Older patients may have a significantly decreased response | Patients may become hypotensive from the vasodilatory effect

How well did you know this?

Not at all

Perfectly

DOPamine Hydrochloride (Intropin)

Type: Endogenous catecholamine, Adrenergic, Vasopressor, Inotropic agent
____________

MOA:
Immediate metabolic precursor to norepinephrine (and dose-depandent effects w/ alpha adrenergic, beta adrenergic, and dompaminergic)| Doses of 1 to 2 mcg/kg/min simulate dopamine receptors; causes vasodilation in the renal, mesenteric, coronary, and intracerebral vascular beds | Doses of 2 to 10 mcg/kg/min simulate beta-1 receptors; increases myocardial contractility and enhancing cardiac impulse conduction | Doses of 10 to 20 mcg/kg/min simulate alpha receptors; resulting in vasoconstriction, increased systemic vascular resistence, and increase in BP | Doses greater than 20 mcg/kg/min, alpha stimulations predominate; resultant vasoconstriction can compromise circulation in the limbs
____________

Indications: Refractory cardiogenic or distributive shock | Hypotension with low cardiac output states | Second-line drug from symptomatic bradycardia
____________

Contraindications: Known hypersensitivity | Hypovolemia | Pheochromocytoma | Uncorrected tachydysrhythmias | VF
____________

Drug Interactions: Inactivated in alkaline solutions (sodium bicarbonate) | MAOIs prolong and potentiate effects | TCAs may potentiate cardiovascular effects | Beta blockers antagonize cardiac effects | When administered with phenytoin, may cause hypotension, bradycardia, and seizures | Simultaneous use of vasopressor may result in severe hypertension
____________

Dosages:
Adult.
IV/IO infusion at 5 to 20 mcg/kg/min, slowly titrated to patient response

Paediatric.
Safety and effectiveness in children have not been established
____________

Duration: Onset: Within 5 minutes | Peak effect: 5 to 10 minutes | Duration: Less than 10 minutes
____________

Special Conditions: Pregnancy safety: Category C | Correct hypovolemia before administering | Should be administered by infusion pump | Extravasation may cause necrosis and sloughing of surrounding tissue | Slow or stop the infusion if tachydysrhythmias or increased ventricular ectopy is observed | Sudden cessation of infusion can result in significant hypotension | Research suggests that pt in cardiogenic or septic shock who are tx’ed w/ norepinephrine have a lower mortality rate than those tx’ed w/ DOPamine

How well did you know this?

Not at all

Perfectly

EPINEPHrine

Type: Sympathomimetic, Sympathetic (alpha/beta adrenergic) agonist
____________

MOA:
Catecholamine with strong alpha adrenergic, strong beta-1, and moderate beta-2 effects | Effects of alpha stimulation result in systemic vasoconstriction, increasing perpheral vascular resistance | Effects of the beta-1 stimulation result in increases in heart rate, myocardial ocntractility, cardiac output, and myocardial oxygen demand | Effects of beta-2 stimulation result in bronchial smooth muscle relaxation | Secondary relaxation effect on the smooth muscle of the stomach, intestine, uterus, and urinary bladder
____________

Drug Interactions: Potentiates other sympathomimetics | Deactivated by alkaline solutions | MAOIs and antidepressants may potentiate effects | Beta blockers may blunt effects
____________

Dosages:
Adult.
Anaphylaxis: 0.3 mg IM in the anterolateral thigh ; Additional epinephrine can be administered every 5 to 15 minutes
If wheezing is present: give nebulized albuterol and/or 5 mL of 1 mg/mL epinephrine nebulized
If stridor is present: consider 5 mL of 1 mg/mL epinephrine nebulized
Severe bronchoconstriction with impending respiratory failure: 0.01 mg/kg of 1 mg/mL IM (0.3 maximum)
(An epinephrine IV infusion can be given when cardiovascular collapse is present)
Profound bradycardia with signs of hemodynamic instability: IV/IO infusion of 0.02 to 0.2 mcg/kg/min titrated to a mean arterial pressure greater than 65 mm Hg or IV/IO push dose 10 to 20 mcg boluses every 2 minutes titrated to a mean arterial pressure greater than 65 mm Hg
Shock unresponsive to IV fluids, or cardiogenic shock with signs of fluid overload: IV/IO infusion 0.05 to 0.3 mcg/kg/min
Cardiac arrest: Give 1 mg (0.1 mg/mL) IV/IO every 3 to 5 minutes during resuscitation. Follow each dose with a 20-mL flush and elevate arm for 10 to 20 seconds after dose ; ET: 2 to 2.5 mg diluted in 10 mL NS

Paediatric.
Anaphylaxis: (If weight is less than 25 kg) give 0.15 mg IM in the anterolateral thigh, (if weight is 25 kg or more) give 0.3 mg IM in the anterolateral thigh ; Additional epinephrine can be administered every 5 to 15 minutes
If wheezing is present: give nebulized albuterol and/or 5 mL of 1 mg/mL epinephrine nebulized
If stridor is present: consider 5 mL of 1 mg/mL epinephrine nebulized
(An epinephrine IV infusion can be given when cardiovascular collapse is present)
Profound bradycardia with signs of hemodynamic instability: IV/IO infusion of 0.01 mg/kg every 3 to 5 minutes (10 mcg maximum)
Cardiac arrest: Give 0.01 mg/kg (0.1 mg/mL) IV/IO every 3 to 5 minutes during arrest (1 mg maximum) ; ET: 0.1 mg/kg (1mg/mL) IV/IO every 3 to 5 minutes during arrest (1 mg maximum dose)
____________

Duration: Onset: Less than 2 minutes IV ; 3 to 10 minutes IM | Peak effect: Less than 5 minutes IV ; 20 minutes IM | Duration: 5 to 10 minutes IV ; 20 to 30 minutes IM
____________

Special Conditions: Pregnancy safety: Category C ; contraindicated for pts in active labour | Carefully document the dosage, concentration, route, time of administration, and patient’s response to each dose | Administer epinephrine as soon as possible in cardiac arrest associated with PEA or asystole | Reduce the dose of epinephrine in patients taking MAOIs, per the local protocols

How well did you know this?

Not at all

Perfectly

Glucagon (GlucaGen)

Type: Hyperglycemic agent, Pancreatic hormone, Insulin antagonist
____________

MOA:
Increases blood glucose level by stimulating the breakdown of stored glycogen to glucose (glycogenolysis) and inhibiting thesynthesis of glycogen from glucose (glycogenesis) | Unknown mechanism of stabilizing cardiac rhythm in beta blocker overdose | Minimal positive inotropic and chronotropic responses | Decreases GI motility and secretions
____________

Indications: Altered mental status when hypoglycemia is suspected | Antidote for symptomatic bradycardia caused by beta blocker or calcium channel blocker overdoses
____________

Contraindications: Known hypersensitivity, pheochromocytoma, hyperglycemia, insulinoma
____________

Adverse Reactions: Dizziness/headache | Hypotension | Tachycardia | N/V | Rebound hypoglycemia
____________

Drug Interactions: Incompatible in solution with most other substances | No significant drug interactions with other emergency medications
____________

Dosages:
Adult.
Hypoglycemia: 1 mg IM/IN; repeat dose until symptoms have resolved
Calcium channel blocker or beta blocker overdose: 5 mg slowly via IV push - repeat in 5 to 10 minutes for total dose of 10mg

Paediatric.
Hypoglycemia: 1 mg IM/IN (≥ 20 kg or 5 years) otherwise 0.5 mg
Calcium channel blocker or beta blocker overdose: 1 mg (25 to 40 kg) or 0.5 mg (less than 25 kg) slowly via IV push every 5 minutes
____________

Duration: Onset: 1 minute | Peak effect: 5 to 20 minutes | Duration: 60 to 90 minutes
____________

Special Conditions: Pregnancy safety: Category B ; use in pregnancy only if clearly indicated | Ineffective if glycogen stores are depleted | Document reassessment of vital signs and mental status after administration

How well did you know this?

Not at all

Perfectly

HydrALAZINE (Apresoline)

Type: Antihypertensive, Vasodilator
____________

MOA:
Relaxes arteriolar, but not venous, smooth muscle | Thought to interefere w/ calcium movement in vascular smooth muscle, which is responsible for vasoconstriction, resulting in lower BP
____________

Indications: Pregnancy-induced hypertension (SBP >= 160 mmHg or DBP >= 100 mmHg) lasting more than 15 minutes with associated preeclampsia symptoms
____________

Contraindications: Known hypersensitivity, CAB, mitral valve rheumatic heart disease | Use with caution in patients with stroke, known renal disease, or hypotension
____________

Adverse Reactions: Headache, nausea, flushing, hypotension, palpitations, tachycardia, dizziness, and angina | Paresthesia, numbness, and tingling
____________

Drug Interactions: MAOIs | Synergistic effects if given simultaneously with other antihypertensives | NSAIDs may diminish the antihypertensive effects
____________

Dosages:
Adult.
5 mg IV; may repeat 10 mg after 20 minutes if indcation persists (goal to decrease MAP by 20%-25%)

Paediatric.
Not usually indicated in the prehospital setting
____________

Duration: Onset: 5 to 20 minutes | Peak effect: 10 to 80 minutes | Duration: 2 to 12 hours
____________

Special Conditions: Pregnancy safety: Category C ; NOT recommended for long-term use during pregnancy | Usually lowers DBP more than SBP

How well did you know this?

Not at all

Perfectly

Lidocaine HCl (Xylocaine)

Type: Antidysrhythmic (Class Ib), Anesthetic
____________

MOA:
Cardiac: Inhibits recovery after repolarization, thereby inhibiting recovery after repolarization, and decreasing myocardial excitability and conduction velocity | Local anesthetic: Inhibits ion transport across the neuronal membrane, blocking conduciton of normal nerve impulses | RSI: May decreases ICP response during laryngoscopy
____________

Indications: Alternative to amiodarone in patients with cardiac arrest from: VT, VF ; Stable monomorphic VT ; or Stable polymorphic VT with normal baseline QT interval when ischemia is treated with electrolyte balance is corrected | Can be used for stable polymorphic VT with baseline QT interval prolongation if TdP is suspected | Can be used as a local anesthetic for various procedures
____________

Contraindications: Hypersensitivity to lidocaine or amide-type local anesthetics, second- or third-degree AV block in the absence of artifical pacemaker, Stokes-Adams syndrome, wide-complex ventricular escape beats w/ bradycardia, Wolff-Parkinson-White Syndrome | Prophylactic use in AMI is contraindicated
____________

Drug Interactions: Apnea induced with succinylcholine may be prolonged by high doses of lidocaine | Cardiac depression may occur in conjunction with administration of IV phenytoin | Procainamide may exacerbate the CNS effects | Metabolic clearance is decreased in patients with liver disease and patients taking beta blockers
____________

Dosages:
Adult.
Cardiac arrest (pulseless VT/VF): Initial does: 1 to 1.5 mg/kg IV/IO. Repeat dose: 0.5 to 0.75 mg/kg IV/IO repeated in 5 to 10 minutes. Maximum total dose: 3 mg/k.
Maintenance infusion: 1 to 4 mg/min
Stable VT and stable regular wide-complex tachycardia: Initial does: 1 to 1.5 mg/kg IV/IO. Repeat dose: 0.5 to 0.75 mg/kg IV/IO repeated in 5 to 10 minutes. Maximum total dose: 3 mg/kg.
Maintenance infusion: 1 to 4 mg/min
Local anesthetic dose varies depending on the procedure and anatomic location. If IO on a conscious pt, consider 0.5 mg/kg of lidocaine 0.1 mg/mL slow push through the IO to max of 40mg to mitigate pain of IO med administration

Paediatric.
IV/IO dose: 1 mg/kg IV/IO push
Maintenance IV/IO infusion: 20 to 50 mcg/kg/mins. Repeat bolus dose if infusion started more than 15 minutes after initial bolus dose
ET dose: 2 to 3 mg/kg
RSI: 1 to 2 mg/kg IV/IO
Local anesthetic dose varies depending on the procedure and anatomic location
____________

Duration: Onset: 1 to 5 minutes | Peak effect: 5 to 10 minutes | Duration: 10 to 20 minutes
____________

Special Conditions: Pregnancy safety: Category B | Reduce the maintenance infusion in the presence of impaired liver function or left ventricular dysfunction | Discontinue the infusion immediately if signs of toxicity develop

How well did you know this?

Not at all

Perfectly

Magnesium sulfate

Type: Electrolyte, Class V antidysrhythmic
____________

MOA:
Depresses the CNS, blocks peripheral neuromuscular transmission, and produces anticonvulsant effects | Decreases the amount of acetylcholine released at the endplate by motor nerve impulses, slows the rate of SA node impulse formation in the myocardium, and prolongs conduction time | Promotes calcium, potassium, and sodium movement in and out of cells and stabilizes excitable membranes | Induces uterine relaxation | Can cause bronchodilation after beta agonists and anticholinergics have been administered
____________

Indications: Management of TdP | Severe bronchoconstriction with impending respiratory failure | Seizure during the third trimester of pregnancy or in the postpartum patient
____________

Contraindications: Known hypersensitivity, heart block, myocardial damage, diabetic coma, hypermagnesemia, hypercalcemia | Use with caution in patients with known renal insufficiency
____________

Drug Interactions: May enhance the effects of other CNS depressants | Serious changes in overall cardiac function may occur with cardiac glycosides
____________

Dosages:
Adult.
Severe hypertension lasting more than 15 minutes with associated preeclampsia symptoms: Give 4 g of a 20% solution IV/IO over 20 minutes, followed by 1 g/h IV/IO, if available
Seizure activity associated with pregnancy greater than 20 weeks’ gestation: Give 4 g of a 50% solution IV/IO over 10 to 20 minutes, followed by 1 g/h IV/IO, if available
Cardiac arrest due to hypomagnesemia or TdP: Give 1 to 2 g IV/IO
TdP with pulse or AMI with hypomagnesemia: Loading dose of 1 to 2 g in 50 to 100 mL of D5W or NS over 5 to 60 minutes IV. Follow with 0.5 to 1 g/h IV
Status asthmaticus: 1 to 2 g IV over 15 to 30 minutes
Severe bronchoconstriction/impending respiratory failure: 40 mg/kg IV over 10 to 15 minutes (2 g maximum)

Paediatric.
Pulseless VT with TdP: 25 to 50 mg/kg IV/IO bolus of a 50% solution (2 g maximum)
TdP with pulses or hypomagnesemia: 25 to 50 mg/kg IV/IO of a 50% solution over 10 to 20 minutes (2 g maximum)
Status asthmaticus: 25 to 50 mg/kg IV/IO of a 50% solution over 15 to 30 minutes (2 g maximum)
____________

Duration: Onset: Immediate | Peak effect: Variable | Duration: 30 minutes
____________

Special Conditions: Pregnancy safety: Category D ; Due to confirmed evidence of human fetal risk, must be used cautiously, although administration may be justified | To treat magnesium toxicity: Stop the infusion, Give calcium gluconate 1 g IV in cases of impending respiratory arrest, Support the patient’s ventilatory effort | Do NOT abbreviate magnesium sulfate to avoid confusion with morphine sulfate

How well did you know this?

Not at all

Perfectly

Milrinone (Primacor)

Type: Inotrope
____________

MOA:
Increases myocardial contractility; Has a direct dilating effect on vascular smooth muscle; Does not possess beta adrenergic properties
____________

Indications: Heart failure in postoperative cardiovascular surgical patients | Shock with high systemic vascular resistance
____________

Contraindications: Known hypersensitivity | Reduce the dose in patients with renal dysfunction
____________

Drug Interactions: Synergistic with catecholamines
____________

Dosages:
Consult medical direction or follow the dosing ordered by the sending physician
____________

Duration: Onset: 5 to 15 minutes | Peak effect: Unknown | Duration: 3 to 6 hours
____________

Special Conditions: Pregnancy safety: Category C | Hemodynamic monitoring is required | Closely monitor BP and heart rate

How well did you know this?

Not at all

Perfectly

NIFEdipine (Procardia, Adalat, Nifedical)

Type: Calcium channel blocker
____________

MOA:
Inhibits movement of calcium ions across cell membranes; Inhibits cardiac and vascular smooth muscle contraction, thereby dilating the main coronary and systemic arteries, reducing preload and afterload, and reducing myocardial oxygen demand; Does NOT prolong AV nodal conduction
____________

Indications: HAPE prevention and treatment | Pregnancy-induced hypertension (SBP >= 160 mmHg or DBP >= 110 mmHg) lasting more than 15 minutes with associated preeclampsia symptoms
____________

Contraindications: Known hypersensitivity to calcium channel blockers | Cardiogenic shock | Immediate-release preparation (sublingually or orally) for urgent or emergent hypertension
____________

Drug Interactions: Beta blockers may potentiate NIFEdipine’s effects | Effects of theophylline may be increased | Antihypertensives may potentiate the hypotensive effects
____________

Dosages:
Adult.
HAPE prevention and treatment: 30 mg of the extended-release preparation orally every 12 hours or 20 mg of the extended-release preparation orally every 8 hours
Pregnancy-induced hypertension: 10 mg orally and may repeat 10 to 20 mg orally every 20 minutes, twice, for persistent, severe hypertension with preeclampsia symptoms. Goal is to reduce MAP by 20% to 25%.

Paediatric.
Data are unavailable
____________

Duration: Onset: 15 to 30 minutes | Peak effect: 1 to 3 hours | Duration: 6 to 8 hours
____________

Special Conditions: Pregnancy safety: Category C | Can be used for HAPE treatment when descent is impossible or delayed and reliable access to supplemental oxygen or portable hyperbaric therapy is unavailable | Hypotension is less common when the extended-release preparation is used but may develop when the medication is given to patients with intravascular volume depletion | Reassess vital signs every 10 minutes during transport

How well did you know this?

Not at all

Perfectly

Nitroglycerin (NGT)

Type: Vasodilator, Nitrate, Antianginal
____________

MOA:
Smooth muscle relaxant, which acts on the vasculature, bronchial, uterine, and intestinal smooth muscle | Dilated peripheral arterioles and veins | Reduces peripheral vascular resistance, preload, and afterload, decreasing the heart’s workload and myocardial oxygen demand
____________

Indications: Ischemic-type chest pain | Acute and symptomatic hypertension | Heart failure | Pulmonary edema
____________

Contraindications: Known hypersensitivity | Hypotension | Hypovolemia | Intracranial bleeding or head injury | Pericardial tamponade | Severe bradycardia or tachycardia | RV infarction | Previous administration of sildenafil or vardenafil within 24 hours or tadalafil within 48 hours | Use with caution in patients with: Hepatic disease, Anemia, Diabetes mellitus, Pregnancy, Breastfeeding
____________

Drug Interactions: Increased hypotensive effect with alcohol, beta blockers, calcium channel blockers, antihypertensives, benzodiazepines, phenothiazines, and other vasodilators | Incompatible with other drugs given IV | Hawthorn increases NTG levels
____________

Dosages:
Adult.
SL: 0.3 to 0.4 mg; may repeat in 3 to 5 minutes to a maximum of 3 doses
Spray: 1 or 2 sprays; may repeat in 3 to 5 minutes to a maximum of 3 doses
NTG IV: 12.5 to 25 mcg bolus (if no SL or spray is given), then begin 10 mcg/min infusion, increase by 10 mcg/min every 3 to 5 minutes until symptom response or desired effect (maximum dose: 200 mcg/min)

Paediatric.
Not recommended
____________

Duration: Onset: 1 to 3 minutes | Peak effect: 5 to 10 minutes | Duration: 20 to 30 minutes SL ; 1 to 10 minutes after discontinuation of IV infusion
____________

Special Conditions: Pregnancy safety: Category C ; has been used safely during pregnancy ; use caution w/ breastfeeding women and monitor infants for adverse effects | Hypotension is more common in older patients | If a 12-lead ECG shows an inferior wall infarct, rule out RV infarction via right-side 12-lead ECG before administering NTG | It must be kept in an airtight container | IV NTG must be administered only with an infusion pump direct from the bottle with a vented IV set and non-polyvinyl chloride tubing | The active ingredient may have stinging effect when administered

How well did you know this?

Not at all

Perfectly

Nitroprusside (Nitropress)

Study These Flashcards

Type: Antihypertensive, Vasodilator
____________

MOA:
Arterial and venous vasodilator that reduces afterload, resulting in decreases BP and increases cardiac output
____________

Indications: Heart failure | Acute and symptomatic hypertension
____________

Contraindications: Known hypersensitivity | Hypotension | Decreased cerebral perfusion | Heart failure with reduced peripheral vascular resistance
____________

Drug Interactions: Additive effects with ganglionic blocking agents, General anesthetics, Other antihypertensives, and Sympathomimetics
____________

Dosages:
Consult medical direction or follow the dosing ordered by the sending physician
____________

Duration: Onset: Immediate | Peak effect: Rapid | Duration: 1 to 10 minutes
____________

Special Conditions: Pregnancy safety: Category C ; caustion w/ use during pregnancy ; contraindicated for use in breastfeeding women | Light sensitive | Keep the drug reservoir and tube covered with an opaque material | Can cause cyanide toxicity

Norepinephrine Bitartrate (Levophed, Levarterenol)

Study These Flashcards

Type: Sympathomimetic, Vasopressor
____________

MOA:
Produces constriction of resistance and capacitance vessels, thereby increasing systemic BP and coronary artery blood flow; also acts on beta-1 receptors | In lower doses, the cardiac-stimulant effect predominates | In larger doses, the vasoconstrictor effect predominates
____________

Indications: First-line vasopressor in neurogenic shock | Hypotension unresponsive to IV/IO fluid resuscitation
____________

Contraindications: Known hypersensitivity | Hypotension caused by hypovolemia | Pregnancy (relative)
____________

Adverse Reactions: Headache | Anxiety, dizziness, restlessness, dyspnea | Hypertension, dysrhythmias, chest pain, peripheral cyanosis, cardiac arrest | Nausea/vomiting | Urinary retention, renal failure | Tissues necrosis from extravasation | Decreased blood flow to the GI tract, kidneys, skeletal muscle, and skin
____________

Drug Interactions: TCAs can markedly increase response to pressors | Concomitant use of sympathomimetics may result in additive cardiovascular effects | Alpha adrenergic effects can be blocked during concurrent administration of phenothiazines | Inactivated by alkaline solutions
____________

Dosages:
Adult.
0.1 to 0.5 mcg/kg/min IV/IO infusion titrated to effect

Paediatric.
Begin at 0.05 to 0.1 mcg/kg/min IV infusion ; Adjust rate to achieve desired change in BP and systemic perfusion ; Maximum infusion rate: 2 mcg/kg/min
____________

Duration: Onset: Immediate | Peak effect: Less than 1 minute | Duration: 1 to 2 minutes
____________

Special Conditions: Pregnancy safety: Category C ; May cause fetal anocia when used in pregnancy | Correct hypovolemia before administering | Use an infusion pump and administer through a large, stable vein to avoid extravasation and tissue necrosis | Close monitoring of the IV/IO site and vital signs is essential | Drug or poison-induced hypotension may require higher doses to achieve adequate perfusion | Lower mortality rate for patients in cardiogenic or septic shock than those treated with DOPamine

Octreotide (Sandostatin)

Study These Flashcards

Type: Synthetic hormone, Antidiarrheal
____________

MOA:
Mimics the actions of the naturally occuring hormone, somatostatin, decreasing viceral blood flow and inhibiting the release of serotonin, gastrin, vasoactive intestinal peptide, secretin, motilin, and pancreatic polypeptide
____________

Indications: Treatment of active GI bleeding during transport
____________

Contraindications: Known hypersensitivity
____________

Drug Interactions: Decreases cycloSPORINE levels
____________

Dosages:
Consult medical direction or follow the dosing ordered by the sending physician
____________

Duration: Onset: 30 minutes | Peak effect: 30 minutes | Duration: Up to 12 hours
____________

Special Conditions: Pregnancy safety: Category B

Oxygen

Study These Flashcards

Type: Naturally occurring atmospheric gas
____________

MOA:
Reverses hypoxemia
____________

Indications: Any suspected cardiopulmonary emergency | Complaints of shortness of breath and ischemic chest discomfort | All other causes of decreased tissue oxygenation
____________

Contraindications: Observe closely when using with patients who have pulmonary conditions that are known to be dependent on hypoxic respiratory drive (very rare)
____________

Adverse Reactions: Decreased level of consciousness | Decreased respiratory drive in patients with COPD | Dry mucous membranes
____________

Drug Interactions: N/A
____________

Dosages:
Adult.
Respiratory and cardiac arrest and carbon monoxide poisoning: 100% and then target an SpO2 of 92% to 98%
If patient is not in respiratory or cardiac arrest: Target an SpO2 of 95% to 98%
ACS: Target an SpO2 of 90% ; AMS, HACE, HAPE: Target an SpO2 higher than 90%

Paediatric.
Respiratory and cardiac arrect: 100% and then target an SpO2 of 94% to 99%
____________

Duration: Onset: Immediate | Peak effect: N/A | Duration: Less than 2 minutes
____________

Special Conditions: Be familiar with liter flow rates and each type of delivery device used

Oxymetazoline (Afrin, Dristan 12-hours, Vicks Sinus-12hours)

Study These Flashcards

Type: Intranasal decongestant, Vasoconstrictor, Topical sympathomimetic
____________

MOA:
Stimulates alpha adrenergic receptors in the arterioles of the nasal mucosa to produce vasoconstriction
____________

Indications: Epistaxis in a patient experiencing facial trauma
____________

Contraindications: Known hypersensitivity | Severe hypertension
____________

Adverse Reactions: Rebound nasal congestion | Nasal mucosa irritation
____________

Drug Interactions: May diminish the vasoconstricting effects of alpha-1 agonists | May enhance the hypertensive effects of sympathomimetics
____________

Dosages:
Adult.
2 to 3 sprays in each nare

Paediatric.
1 to 2 sprays in each nare
____________

Duration: Onset: Immediate | Peak effect: 5 minutes | Duration: Up to 5 hours
____________

Special Conditions: Pregnancy safety: Category B

Oxytocin (Pitocin)

Study These Flashcards

Type: Pituitary hormone, Uterine vasoconstrictor
____________

MOA:
Binds to oxytocin receptor sites on the surface of uterine smooth muscle, Increases the force and frequency of uterine contractions | Causes dilation of vascular smooth muscle, thereby increasing renal, coronary, and cerebral blood flow
____________

Indications: Postpartum hemorrhage due to uterine atony after infant and placental delivery
____________

Drug Interactions: Can cause severe, persistent hypertension if administered with vasopressors | Synergistic effect with black cohosh, cotton root, squaw vine, and cinnamon
____________

Dosages:
Adult.
IM administration: 10 units IM after delivery of placent ; IV/IO administration: Mix 10 to 40 units in 1,000 mL of a compatible IV solution infused at 10 to 15 drops/min, titrated to the severity of bleeding and uterine response

Paediatric.
N/A
____________

Duration: Onset: 3 to 5 minutes IM ; Within 1 minute IV/IO | Peak effect: 40 minutes IM ; Unknown IV/IO | Duration: 2 to 3 hours IM ; 1 hour after IV/IO infusion is stopped
____________

Special Conditions: Pregnancy safety: Category C | Closely monitor vital signs, including fetal heart rate and uterine tone

Phenylephrine (Neo-Synephrine)

Study These Flashcards

Type: Adrenergic, Alpha agonist, Nasal vasoconstrictor
____________

MOA:
Stimulates alpha adrenergic receptors in the arterioles of the nasal mucosa to produce vasoconstriction
____________

Indications: Epistaxis; To reduce bleeding during nasotracheal intubation
____________

Contraindications: Known hypersensitivity | Use with extreme caution in geriatric patients with preexisting cardiovascular disease
____________

Adverse Reactions: Tremors | Palpitations | Hypertension
____________

Drug Interactions: Exaggerated adrenergic effects if given with, or up to 21 days after, MAOI administration | Hypertensive effects may be potentiated by TCAs, guanethidine, methyldopa, and atropine-like drugs
____________

Dosages:
Adult.
Two sprays in the selected nare before nasotracheal tube insertion

Paediatric.
N/A
____________

Duration: Onset: Seconds | Peak effect: 30 minutes | Duration: 30 minutes to 4 hours
____________

Special Conditions: Pregnancy safety: Category C | Each bottle is for single-patient use

Procainamide Hydrochloride (Pronestyl)

Study These Flashcards

Type: Class Ia antidysrhythmic
____________

MOA:
Inhibits recovery after repolarization, resulting in decreased myocardial excitability and conduction velocity | Direct membrane depressant that decreases conduction velocity, prolongs the refractory period, decreases automaticity, and reduces repolarization abnormalities
____________

Indications: Stable monomorphic VT with normal QT interval | Reentry SVT uncontrolled by vagal maneuvers and adenosine if BP is stable | Stable wide-complex tachycardia of unknown origin | AF with a rapid ventricular rate in patients with Wolff-Parkinson-White syndrome
____________

Contraindications: Known hypersensitivity to procainamide or other ingredients | TdP | Second- and third-degree heart AV block | Systemic lupus erythematosus | Preexisting QT prolongation | Digitalis toxicity | TCA overdose | Administer with caution to patients with: Asthma or digitalis-induced dysrhythmias; Myasthenia gravis; Cardiac, hepatic, or renal insufficiency
____________

Drug Interactions: Additive effect with other antidysrhythmic agents | Use with beta agonists may be associated with adverse cardiovascular effects, including QT interval prolongation
____________

Dosages:
Adult.
Recurrent VF/pulseless VT: 20 mg/min slow IV infusion until the dysrhythmia is suppressed ; Maximum total dose: 17 mg/kg
In urgent situations: up to 40 mg/min may be administered, up to a total dose of 17 mg/kg
Other indications: 20 mg/min slow IV infusion until dysrhythmia suppression, hypotension, QRS widens by more than 50% of its pretreatment width, or a maximum dose has been given
Maintenance infusion: 1 to 4 mg/min (diluted in D5W or NS);
(In the presence of cardiac, hepatic, or renal dysfunction, reduce the maximum total dose to 12 mg/kg and the maintenance infusion to 1 to 2 mg/min)

Paediatric.
NOT recommended in the prehospital setting
____________

Duration: Onset: 10 to 30 minutes | Peak effect: Variable | Duration: 3 to 6 hours
____________

Special Conditions: Pregnancy safety: Category C | Hypotension may occur with rapid infusion

Sodium bicarbonate

Study These Flashcards

Type: Systemic hydrogen ion buffer, Alkalizing agent
____________

MOA:
Reacts with hydrogen ions to form water and carbon dioxide, correcting metabolic acidosis | Increases blood and urinary pH by releasing a bicarbonate ion, which in turn neutralizes hydrogen ion concentrations
____________

Indications: Management of cardiac arrest in which either hyperkalemia or TCA overdose is suspected | QRS prolongation in known or suspected TCA overdose | Crush syndrome
____________

Adverse Reactions: Electrolyte imbalance, heart failure, and pulmonary edema | Tremors, twitching, and seizures caused by alkalosis
____________

Drug Interactions: Increases the effects of amphetamines | Decreases the effects of benzodiazepines and TCAs | May deactivate sympathomimetics
____________

Dosages:
Adult.
1 mEq/kg slow IV/IO push

Paediatric.
1 mEq/kg slow IV/IO push (4.2% concentration recommended for infants younger than 1 month) ; Consult medical direction for repeat dosing orders
____________

Duration: Onset: Seconds | Peak effect: Less than 15 minutes | Duration: 1 to 2 hours
____________

Special Conditions: Pregnancy safety: Category C | Monitor the patient closely for signs and symptoms of fluid overload | Ensure the patient has adequate airway and ventilatory support | May precipitate or inactivate other medications | Flush the IV line well before and after injecting sodium bicarbonate | Extravasation may lead to tissue sloughing, cellulitis, and necrosis at the injection site

Tranexamic Acid (Cyklokapron, Lysteda)

Type: Hemostatic agent, Antifibrinolytic agent, Plasminogen inhibitor ____________ MOA: Inhibits the activation of plasminogen, thereby reducing the conversion of plasminogen to plasmin (which breaks down fibrin clots, fibrinogen, and other plasma protiens) | Now, Clotting factors and circulating platelet plugs can form a seal (fibrin clot) and reduce bleeding ____________ Indications: Blunt or penetrating trauma less than 3 hours from onset with hemodynamic compromise, bleeding ____________ Contraindications: Known hypersensitivity | Mechanism of injury more than 3 hours prior to EMS care | Subarachnoid hemorrhage | History of PE, DVT, or other thromboembolic disorder | Reduce the dose in patients with renal insufficiency ____________ Adverse Reactions: Fatigue | Headache | Dizziness | Abdominal and back pain | Joint pain | Musculoskeletal pain | Anemia | Rapid infusion may cause hypotension | May increase the risk of thromboembolic disorders ____________ Drug Interactions: Hormonal contraceptives and clotting factor complexes increase the risk of thromboembolic disorders ____________ Dosages: Adult. 1 g IV infusion over 10 minutes Paediatric. Not recommended ____________ Duration: Onset: Unknown | Peak effect: Unknown | Duration: 7 to 8 hours ____________ Special Conditions: Pregnancy safety: Category B | Must be mixed into an infusion bag, typically 100 mL of NS | Medscape provides little information related to EMS use

Verapamil Hydrochloride (Isoptin, Calan)

Type: Calcium channel blocker ____________ MOA: Slows AV node conduction, Shortens the refractory period of accessory pathways, and Acts as a negative inotrope and vasodilator ____________ Indications: Stable narrow-QRS tachycardia if the rhythm persists despite vagal maneuvers or adenosine or if the tachycardia is recurrent | To control the ventricular rate in patients with AF or atrial flutter without preexcitation ____________ Contraindications: Known hypersensitivity | Wolff-Parkinson-White syndrome, Lown-Ganong-Levine syndrome | Second- or third-degree AV block, sick sinus syndrome, or other sinus node disease without an artificial pacemaker present | Hypotension, cardiogenic shock, severe left ventricular dysfunction, wide-complex tachycardias | Children younger than age 12 months | Use with extreme caution in patients receiving oral beta blockers ____________ Adverse Reactions: Dizziness, headache, dysrhythmias, nausea/vomiting | Can decrease myocardial contractility ____________ Drug Interactions: Increases the serum concentration of digoxin | Simultaneous administration with IV beta blockers can produce severe hypotension | Antihypertensives may potentiate the hypotensive effects | May potentiate the activity of depolarizing and nondepolarizing neuromuscular blocking agents | Increased risk of sudden cardiac death when given concurrently with erythromycin | St. John’s wort can reduce its effectiveness ____________ Dosages: Adult. 2.5 to 5 mg IV bolus over 2 minutes (3 minutes in older patients) ; Repeat dose of 5 to 10 mg may be given every 15 to 30 minutes to a maximum total dose of 20 mg Alternative dosing: 5 mg IV bolus every 15 minutes to a total dose of 30 mg Paediatric. Consult medical direction ____________ Duration: Onset: 2 to 5 minutes | Peak effect: Variable | Duration: 10 to 20 minutes ____________ Special Conditions: Pregnancy safety: Category C | Carefully monitor BP, heart rate, and ECG before, during, and after administration | AV block or asystole may occur because of slowed AV conduction

General Cardiovascular Flashcards

List of meds that have some impact on cardiovascular system. Noninclusive to diretics, IV fluids, and electrolytes (26 cards)